medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2019-13-172-177medsovet-4098Research ArticleОбмен опытомSharing experiencesТревога в гинекологии: три клинические ситуацииAnxiety in gynecology: three clinical caseshttps://orcid.org/0000-0001-9081-9041БурчаковД. И.BurchakovD. I.

Бурчаков Денис Игоревич, доцент, кафедра эндокринологии

107023, Москва, ул. Малая Семеновская, д. 3А, стр. 2, офис 410

Denis I. Burchakov, Associate Professor, Chair for Endocrinology, Non-State Educational Private Institution of Continuing Professional Education «Higher Medical School»

Office 410, 3A/2 Malaya Semenovskaya Street, Moscow, 107023

dr.denis.burchakov@gmail.comhttps://orcid.org/0000-0001-6331-3109ЧиловаР. А.ChilovaR. A.

Чилова Раиса Алексеевна, доктор медицинских наук, профессор, кафедра акушерства и гинекологии

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Raisa A. Chilova, Dr. of Sci. (Med.), Professor, Chair for Obstetrics and Gynecology

8, p. 2, Trubetskaya Street, Moscow, 119991

rtchilova@gmail.comВысшая медицинская школаРоссияHigher Medical SchoolRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University)Russian Federation201910102019013172177Copyright © Бурчаков Д.И., Чилова Р.А., 20192019Бурчаков Д.И., Чилова Р.А.Burchakov D.I., Chilova R.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/4098

Тофизопам – это анксиолитик, который допустимо применять в практике гинеколога. В данном обзоре рассмотрены три типичные клинические ситуации, в которых тревога женщины сказывается на ее соматическом состоянии, и врачу-гинекологу удалось ее скорректировать. Обсуждаются возможные сочетания тофизопама с гормональной терапией, а также его эффективность и безопасность.

Tofisopam is an anxiolytic drug, available for prescription by gynecologist. This paper discusses three typical case vignettes, where woman’s anxiety interfered with her somatic condition and responded on tofisopam. There is also a discussion of combination of tofisopam with hormonal therapy and it’s efficacy and safety.

тофизопампредменструальный синдромпослеродовый периодклимактерический синдромtofisopampremenstrual syndromepostpartumclimacteric syndromeReferencesДюкова Г.М., Саксонова, Е.В., Голубев В.Л. Грандаксин в неврологической практике (мультицентровое исследование). Журнал неврологии и психиатрии им. C.C. Корсакова. 2009;(9):44–48. Режим доступа: https://elibrary.ru/item.asp?id=13123955.Diukova G.M., Saksonova E.V., Golubev V.L. Grandaxin in neurological practice. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2009;(9):44–48. (In Russ.) Available at: https://elibrary.ru/item.asp?id=13123955.O’Brien P.M., Backstrom T., Brown C., Dennerstein L., Endicott J., Epperson C.N., Eriksson E., Freeman E., Halbreich U., Ismail K.M., Panay N., Pearlstein T., Rapkin A., Reid R., Schmidt P., Steiner M., Studd J., Yonkers K.Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13-21. doi: 10.1007/s00737-010-0201-3.O’Brien P.M., Backstrom T., Brown C., Dennerstein L., Endicott J., Epperson C.N., Eriksson E., Freeman E., Halbreich U., Ismail K.M., Panay N., Pearlstein T., Rapkin A., Reid R., Schmidt P., Steiner M., Studd J., Yonkers K.Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13-21. doi: 10.1007/s00737-010-0201-3.Foster R.,•Vaisberg M., Bachi A.L.L., dos Santos J.d.M.B., de Paula Vieira R., LunaJunior L.A.,•Araujo M.P., Parmigiano T.R., Borges F., Di-Bella Z.I.K.J. Premenstrual Syndrome, Inflammatory Status, and Mood States in Soccer Players. Neuroimmunomodulation. 2019;26:1–6. https://doi.org/10.1159/000494559Foster R.,•Vaisberg M., Bachi A.L.L., dos Santos J.d.M.B., de Paula Vieira R., LunaJunior L.A.,•Araujo M.P., Parmigiano T.R., Borges F., Di-Bella Z.I.K.J. Premenstrual Syndrome, Inflammatory Status, and Mood States in Soccer Players. Neuroimmunomodulation. 2019;26:1–6. https://doi.org/10.1159/000494559Jung S.J., Roberts A.L., Chocano-Bedoya P., Whitcomb B.W., Missmer S.A., Manson J.E., Hankinson S.E., Bertone-Johnson E.R., Koenen K.C. Posttraumatic stress disorder and development of premenstrual syndrome in a longitudinal cohort of women. Archives of Women s Mental Health. 2018;22(9). doi: 10.1007/s00737-018-0916-0.Jung S.J., Roberts A.L., Chocano-Bedoya P., Whitcomb B.W., Missmer S.A., Manson J.E., Hankinson S.E., Bertone-Johnson E.R., Koenen K.C. Posttraumatic stress disorder and development of premenstrual syndrome in a longitudinal cohort of women. Archives of Women s Mental Health. 2018;22(9). doi: 10.1007/s00737-018-0916-0.Arslantaş H., Abacigil F., Cinakli Ş. Relationship between premenstrual syndrome and basic personality traits: a cross-sectional study. Turkey Sao Paulo Med J. Original article. 2018;136(4):339–345. doi: 10.1590/15163180.2018.0061240418.Arslantaş H., Abacigil F., Cinakli Ş. Relationship between premenstrual syndrome and basic personality traits: a cross-sectional study. Turkey Sao Paulo Med J. Original article. 2018;136(4):339–345. doi: 10.1590/15163180.2018.0061240418.Bertone-Johnson E.R., Whitcomb B.W., Rich-Edwards J.W., Hankinson S.E., Manson J.E. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol. 201 Dec 15;182(12):1000-9. doi: 10.1093/aje/kwv159.Bertone-Johnson E.R., Whitcomb B.W., Rich-Edwards J.W., Hankinson S.E., Manson J.E. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol. 201 Dec 15;182(12):1000-9. doi: 10.1093/aje/kwv159.Lopez L.M., Kaptein A.A., Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(2):CD006586. doi: 10.1002/14651858.CD006586.pub4.Lopez L.M., Kaptein A.A., Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(2):CD006586. doi: 10.1002/14651858.CD006586.pub4.Praharaj S.K., Arora M., Sarkhel S. Sensory disturbances associated with serotonin reuptake inhibitors: brief review. Human Psychopharmacology. 2010;25(3):216–221. doi: 10.1002/hup.1109.Praharaj S.K., Arora M., Sarkhel S. Sensory disturbances associated with serotonin reuptake inhibitors: brief review. Human Psychopharmacology. 2010;25(3):216–221. doi: 10.1002/hup.1109.Howard L.M., Molyneaux E., Dennis C.-L., Rochat T., Stein A., Milgrom J. Non-psychotic mental disorders in the perinatal period. The Lancet. 2014;384:1775-1788. doi: 10.1016/S0140-6736(14)61276-9.Howard L.M., Molyneaux E., Dennis C.-L., Rochat T., Stein A., Milgrom J. Non-psychotic mental disorders in the perinatal period. The Lancet. 2014;384:1775-1788. doi: 10.1016/S0140-6736(14)61276-9.Stewart D.E., Vigod S.N. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. Annual Review of Medicine. 2019;70:183–196. doi: 10.1146/annurev-med-041217-011106.Stewart D.E., Vigod S.N. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. Annual Review of Medicine. 2019;70:183–196. doi: 10.1146/annurev-med-041217-011106.Dale-Hewitt V., Slade P., Wright I. et al. Patterns of attention and experiences of post-traumatic stress symptoms following childbirth: an experimental study. Arch Womens Ment Health. 2012;15(4):289-296. doi: 10.1007/s00737-012-0290-2.Dale-Hewitt V., Slade P., Wright I. et al. Patterns of attention and experiences of post-traumatic stress symptoms following childbirth: an experimental study. Arch Womens Ment Health. 2012;15(4):289-296. doi: 10.1007/s00737-012-0290-2.Stewart D.E., Vigod S. Postpartum depression. N Engl J Med. 2016;375(22):2177–2186. doi: 10.1056/NEJMcp1607649.Stewart D.E., Vigod S. Postpartum depression. N Engl J Med. 2016;375(22):2177–2186. doi: 10.1056/NEJMcp1607649.Sober S., Schreiber C.A. Postpartum contraception. Clin Obstet Gynecol. 2014;57(4):763-76. doi: 10.1097/GRF.0000000000000055.Sober S., Schreiber C.A. Postpartum contraception. Clin Obstet Gynecol. 2014;57(4):763-76. doi: 10.1097/GRF.0000000000000055.Bromberger J.T., Kravitz H.M., Chang Y., Randolph J.F., Avis N.E., Gold E.B., Matthews K.A. Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation. Menopause. 2013;20(5):488-495. doi: 10.1097/gme.0b013e3182730599.Bromberger J.T., Kravitz H.M., Chang Y., Randolph J.F., Avis N.E., Gold E.B., Matthews K.A. Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation. Menopause. 2013;20(5):488-495. doi: 10.1097/gme.0b013e3182730599.Siegel A.M., Mathews S.B. Diagnosis and Treatment of Anxiety in the Aging Woman. Curr. Psychiatry Rep. 2015;17:93. doi: 10.1007/s11920-015-0636-3.Siegel A.M., Mathews S.B. Diagnosis and Treatment of Anxiety in the Aging Woman. Curr. Psychiatry Rep. 2015;17:93. doi: 10.1007/s11920-015-0636-3.Bonnet N., Bernard P., Beaupied H., Bizot J.C., Trovero F., Courteix D.; Benhamou C.L. Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol. 2007;221(1):111-118. doi: 10.1016/j.taap.2007.02.005.Bonnet N., Bernard P., Beaupied H., Bizot J.C., Trovero F., Courteix D.; Benhamou C.L. Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol. 2007;221(1):111-118. doi: 10.1016/j.taap.2007.02.005.

The authors declare that there are no conflicts of interest present.